Dr. Ojamies currently serves as Product Director for data42, Novartis - a transformational R&D program to leverage 2 million patient-years of data in one of the largest and most diverse datasets in the pharma industry, with the ultimate moonshot goal to change the way we develop medicines. Dr. Ojamies leads the strategy and development of user-facing products aimed at providing greater access to clinical & RWE data as well as collaborative product solutions for improved patient stratification, safety, and trial optimization thereby reimagining the drug discovery and development process. She brings in extensive experience from the life sciences, technology, and startup world to develop product solutions in drug research and development. Dr. Ojamies obtained her Ph.D. in Clinical Hematology and Oncology from the University of Helsinki and went on to work with BenevolentAI and Novartis. She has contributed significantly in the space of product development leveraging big data and AI for drug discovery.